Indivior
Richmond · Founded 2014
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $850.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2026)
- Ticker: lse:INDV
- Website: indivior.com
- Phone: +1 804 379 1090
Industries & Categories
Addiction Treatment, Biotechnology, Communities, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/indivior-65400 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.